Skip to content
Low DoseGLP-1Providers

Provider review

Ozari Health review

Two of the lowest entry prices here, with nothing published above them.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated August 2026

We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.

From $86/mo semaglutide and $125/mo tirzepatide

Visit Ozari Health

A figure far below the field is usually one of three things, and the page distinguishes none of them.

Price as published

Ozari Health

From $86/mo semaglutide and $125/mo tirzepatide

Vs median
$89/mo below the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

In one paragraph

The verdict

These are the two lowest entry figures we have come across, and that is a reason to read carefully rather than a reason to click. A price well below the rest of the field is usually one of three things: a genuinely low-cost operator, an introductory rate that steps up, or the bottom rung of a ladder whose other rungs are not shown. Ozari publishes nothing that tells you which. Both figures are introduced as starting points, no ladder appears anywhere on the site, and nothing states what a working dose costs or when the entry rate ends. What the cards do list is specific and reasonable — weekly self-injection, doctor-monitored dosing, free shipping, cancel anytime — so the service is described even though the price is not resolved. Read the two figures as the cheapest amount this seller will ever charge you, not as the cost of a course of treatment, and ask what the second month costs before you pay for the first.

Visit Ozari Health

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

  • You are testing the water and want the lowest possible entry cost
  • You will ask what the second month costs before paying for the first
  • You want both molecules available from one provider

Look elsewhere if

  • You are budgeting a full course. Nothing above the entry figure is published
  • You want to know when the entry rate ends
  • You want a dose behind the number

What it actually costs

Price as published

From $86/mo semaglutide and $125/mo tirzepatide

Vs median
$89/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
Market
$59–$1,300/mo is the full published spread on this site
Structure
Standard plan, self-directed low dose

No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.

235 of the 548 programs here price a small dose this way. The two lowest entry figures here, and nothing above them is published — no ladder, no standing rate, no statement of what a working dose costs. A price far below the field is evidence of one of three things and the page distinguishes none of them, so the figures should be read as the cheapest this seller will ever charge rather than as the cost of a course. No low-dose product and no dose published.

See Ozari Health's current price

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult
Included in the price
Dietitian
Not confirmed
Labs
Not required
Pricing
Check plan terms

What it does well

  • The two lowest entry prices we have found, with both molecules offered.
  • Free shipping and doctor-monitored dosing are named as included.
  • Cancel anytime is stated on the page.

Pharmacy, labs and oversight

Ozari Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Transparency check

2 of 4 published openly

What Ozari Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
Not published
A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
Published
What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
Not published
No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
None on file

How the program works

These are the two lowest entry figures on the page, and that is the reason to read the row carefully rather than the reason to click it. A price well below the field is usually one of three things: a genuine low-cost operator, an introductory rate that steps up, or the bottom rung of a ladder whose other rungs are not shown. Ozari publishes nothing that distinguishes between them. Both figures are introduced as starting points, no ladder appears anywhere, and no statement is made about what a working dose costs or when the entry rate ends. What the cards do list is reasonable and specific — weekly self-injection, doctor-monitored dosing, free shipping, cancel anytime — so the offering is described even though the price is not resolved. Treat the two figures as the cheapest thing this seller will ever charge, not as what a course costs.

The honest cons

Both figures are floors, and no rung above either is published anywhere.
  • Nothing says what a working dose costs or when the entry rate ends.
  • No milligram appears against either price.
Visit Ozari Health

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

Ozari Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Also consider

Two more programs that price a small dose the way Ozari Health does. Both are partners: we may earn a commission if you start care through these links.

Partner

Direct Meds

From $249/mo sublingual · $297/mo injection

Standard plan, self-directed low dose

FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.

Partner

Peter MD

$149/mo GLP1+B12 · $249/mo tirz (quarterly)

Standard plan, self-directed low dose

Where this sits

#311 of 548

Ordered with the companies that pay us first, and Ozari Health is not one of them. A disclosed partition, not a score.

Compare all 548 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Start with Ozari Health

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

Strut Health

$99/mo sema lozenge (auto-refill)

FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.

Vs median
$76/mo below the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the Strut Health review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.